Alfain Technologies (Pvt) Limited company information, Employees & Contact Information

FDA Grants Breakthrough Therapy Designation to Ficerafusp Alfa in Head and Neck Cancer CUREtoday.com

Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trial Nature

FDA Outlines Next Steps for Development of Eftilagimod Alfa in PD-L1–Negative HNSCC OncLive

Marengo Presents Expanded Clinical Monotherapy Activity of Invikafusp Alfa in Multiple PD-1 Resistant Tumors as a Clinical Plenary Oral at AACR 2025 PR Newswire

Phase II win for Boston Pharma’s efimosfermin alfa in MASH The Pharma Letter

Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia ScienceDirect.com

Positive Data for efdoralprin alfa in Alpha-1 Emphysema respiratory-therapy.com

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index Italian Journal of Pediatrics

Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial The Lancet

A real-world pharmacovigilance study of efgartigimod alfa in the FDA adverse event reporting system database Frontiers

Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease The New England Journal of Medicine

FDA Grants RMAT Designation to Nogapendekin Alfa in Pancreatic Cancer Targeted Oncology

Biohaven Enrolls First Patient in Phase 3 Trial of Taldefgrobep alfa in Spinal Muscle Atrophy (SMA) PR Newswire

Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study ScienceDirect.com

Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure The New England Journal of Medicine

Efficacy and Safety of Luspatercept versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naïve Patients with Transfusion-Dependent Lower-Risk Myelodysplastic Syndromes: Full Analysis of the COMMANDS Trial OncLive

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial The Lancet

A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease The New England Journal of Medicine

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial The Lancet

A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency The New England Journal of Medicine

Phase 2 Trial of Bintrafusp Alfa in Frontline Biliary Tract Cancer Discontinued OncLive

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Nature

Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials Nature

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial The Lancet

Comparison of efficacy between beractant and poractant alfa in respiratory distress syndrome among preterm infants (28–33+6 weeks gestational age) using the less invasive surfactant administration (LISA) technique: A randomized controlled trial | Journal of Nature

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial The Lancet

Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease Nature

Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease Neurology® Journals

Netflix Adapting 'Machos Alfa' in Germany, Season 4 Ordered in Spain Variety

BioMarin Announces Approval of Vimizim® (elosulfase alfa) in China for Treatment of Morquio A Syndrome PR Newswire

A Randomized, Controlled Trial to Investigate the Efficacy of Nebulized Poractant Alfa in Premature Babies with Respiratory Distress Syndrome The Journal of Pediatrics

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease The New England Journal of Medicine

Secondary Analyses of ANNEXA-I Trial Assessing Andexanet Alfa in Intracranial Hemorrhage: Ashkan Shoamanesh, MD | NeurologyLive - Clinical Neurology News and Neurology Expert Insights NeurologyLive

What Does 'Alfa' In Alfa Romeo's Name Stand For? SlashGear

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma The New England Journal of Medicine

Federal appeals court reverses ruling for Alfa in Alabama disability discrimination case AL.com

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer The New England Journal of Medicine

argenx Announces Approval of VYVGART (efgartigimod alfa) in GlobeNewswire

Efficacy and Safety of Epoetin Alfa in Critically Ill Patients The New England Journal of Medicine